NIPH Clinical Trials Search

JAPANESE
JRCT ID: jRCT1062260006

Registered date:09/04/2026

HiSCO-15A study

Basic Information

Recruitment status Recruiting
Health condition(s) or Problem(s) studiedRectal Cancer
Date of first enrollment09/04/2026
Target sample size37
Countries of recruitment
Study typeInterventional
Intervention(s)After abdominoperineal resection, the perineal wound is closed using a semi-closure technique. On postoperative day 1, a negative pressure wound therapy (NPWT) device is applied to the perineal wound. A dressing material is applied to the wound, and negative pressure is initiated.

Outcome(s)

Primary OutcomeIncidence of perineal surgical site infection (SSI) within 30 days after surgery
Secondary Outcome1,Overall incidence of surgical site infection (SSI) 2,Incidence of SSI by anatomical site (Superficial, Deep, Organ/Space) 3,Length of hospital stay 4,Postoperative complications (Clavien-Dindo classification) 5,Causative pathogens of surgical site infection 6,Incidence of skin disorders associated with negative pressure wound therapy (NPWT)

Key inclusion & exclusion criteria

Age minimum>= 18age old
Age maximumNot applicable
GenderBoth
Include criteria(1) Patients scheduled to undergo abdominoperineal resection (APR) for colorectal surgery. (2) Patients diagnosed with colorectal cancer histologically according to the "Japanese Classification of Colorectal, Appendiceal, and Anal Carcinoma (9th Edition)," who have received preoperative radiotherapy and are scheduled for Negative Pressure Wound Therapy (NPWT). (3)/(4) Patients aged 18 years or older who have provided written informed consent prior to study enrollment.
Exclude criteria(1) Patients with contaminated perineal wounds accompanied by active infection. (2) Patients with known hypersensitivity to chemical substances (e.g., urethane, polyvinyl alcohol, acrylic adhesives). (3) Patients with comorbid psychiatric disorders that may interfere with the evaluation of the efficacy and safety of this study. (4) Other patients judged by the investigator or sub-investigator to be unsuitable for participation in the study.

Related Information

Contact

Public contact
Name Manabu Shimomura
Address 1-2-3 Kasumi, Minami-ku, Hiroshima city, Hiroshima JAPAN Hiroshima Japan 734-8551
Telephone +81-82-257-5222
E-mail mshimo@hiroshima-u.ac.jp
Affiliation Hiroshima University Hospital
Scientific contact
Name Hideki Ohdan
Address 1-2-3 Kasumi, Minami-ku, Hiroshima city, Hiroshima JAPAN Hiroshima Japan 734-8551
Telephone +81-82-257-5222
E-mail hohdan@hiroshima-u.ac.jp
Affiliation Hiroshima University Hospital